Malibu Life Holdings Limited - Announcement of Share Issuance
· Issued by Malibu Life Holdings Limited
ALLOTMENT OF SHARES AND ADMISSION TO TRADING
Date: 11 September 2026
Company: Malibu Life Holdings Limited
LEI: 549300WXTCG65AQ7V644
Malibu Life Holdings Limited
(the "Company")
Issuance of shares in connection with vested awards
In accordance with an announcement of transactions by persons discharging
managerial responsibilities published by the Company on 9 June 2026, pursuant to
the vesting of certain conditional awards over ordinary shares of $0.01 each in
the Company on 8 June 2026 granted subject to the rules of the Malibu Life
Omnibus Incentive Plan, the Company announces the allotment and issue of 84,999
ordinary shares of $0.01 each in the Company ("New Ordinary Shares") to satisfy
such awards.
The Company has applied to the London Stock Exchange for the New Ordinary Shares
to be admitted to trading on the Main Market for listed securities of the London
Stock Exchange (the "Main Market") and admission to trading on the Main Market
is expected to occur at or around 8.00 a.m. on 15 September 2026 ("Admission").
Total voting rights
Immediately following Admission, the Company will have 25,777,809 Ordinary
Shares in issue and admitted to trading on the Main Market, and its issued share
capital will be:
· 25,777,809 Ordinary Shares of US$0.01 each with one vote per share; and
· 17,185,206 B Shares of US$0.01 each with one vote per share.
Therefore, the total number of voting rights in the Company immediately
following Admission will be 42,963,015. The Company holds no shares in treasury.
The above figure of 42,963,015 may be used by shareholders as the denominator
for the calculation by which they will determine if they are required to notify
their interest in, or a change in their interest in, the share capital of the
Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries
Company Secretary +1 (345) 814-7600
Walkers Corporate Limited
Investor Contact ir@malibulifeinsurance.com
Investor relations (212) 715-6707
This information was brought to you by Cision http://news.cision.com
